The U.S. Food and Drug Administration (FDA) has issued an approval (status AP) for application number ANDA087564 submitted by Sun Pharm Industries.
The approved product is an oral tablet of Isosorbide Dinitrate, 30 mg strength, identified as product number 001. The product is listed with a marketing status of "Discontinued" and is not a reference drug.
The submission history includes multiple supplemental (SUPPL) filings covering manufacturing (CMC) and labeling, with submission numbers ranging from 1 to 19 and approval dates from 1984 to 1998.
No reference standard is indicated for this product.
Regulatory UpdatesSep 15, 2026•1 min read
FDA Approves ANDA087564 for Isosorbide Dinitrate Tablet
The FDA approved application ANDA087564 for Sun Pharm Industries' oral tablet Isosorbide Dinitrate 30 mg, listed with a discontinued marketing status.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating